See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI101.11▲ 1.65%
← IQE page
XStocksXray
Market X-Ray report · 22 October 2026

IQE PLC (IQE)

London Exchange · UK · prices in GBX · close of 22 Oct 2026

Key indicators

Last closeGBX 36.00
52-week range4.75 – 72.90
Return, 1 month / 3 months−20.8% / −25.6%
Return, 1 year / 3 years+421.7% / +118.4%
TrendBelow its 200-day average
RSI (14)32
Volatility (1 year)133.7%
Worst drawdown (1 year)-49.2%
Average daily value traded635.12M GBX
Dividend yield–

Market X-Ray price-based

44/ 100 · High confidence · ahead of 37% of stocks on this exchange
Trend53
Momentum38
Stability (higher is calmer)12
Liquidity96
Income–

Five-year price chart navy: price · brown: 200-day average

1.3917.6733.9450.2166.492021-102023-012024-042025-072026-10

About the company

IQE makes advanced semiconductor wafers and materials, specialising in compound semiconductors grown as thin crystalline layers on wafers. These wafers are used in chips for wireless communications, photonics, infrared sensing and power devices. The company supplies chipmakers and device manufacturers who build components for consumer electronics, communications networks and sensing equipment. IQE is based in the United Kingdom and serves customers in markets around the world.

The shares are listed on the London Exchange in UK under the code IQE, and the price on this page is in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

IQE PLC (IQE) trades on the London Exchange in UK. It last closed at GBX 36.00 on 22 October 2026.

Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 2,380 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 421.7% and over the last three months it fell 25.6%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
IQE PLC (IQE)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend53 · FairMixed trend against its averages.
Above 200-day average-2.0%
From 52-week high-42.9%
Momentum38 · WeakLagging most stocks on this exchange.
3-month return-25.6%
6-month return-42.5%
12-month return, skipping the last month558.7%
Stability (higher is calmer)12 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)133.7%
Worst drawdown, 1 year (smaller is calmer)-49.2%
Liquidity96 · StrongTrades actively.
Average daily value traded635.12M GBX
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−8.5%
1 month−20.8%
3 months−25.6%
6 months−42.5%
1 year+421.7%
3 years+118.4%
5 years−21.7%

Signals

50-day / 200-day average45.97 / 36.73
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)3.21

Technical summary

DailyStrongly bearish3 bullish · 1 neutral · 12 bearish
WeeklyNeutral6 bullish · 1 neutral · 5 bearish
MonthlyBullish5 bullish · 1 neutral · 2 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 23 Oct 2026